
Sign up to save your podcasts
Or


Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643
By Michael Putman4.9
114114 ratings
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643

503 Listeners

296 Listeners

129 Listeners

3,367 Listeners

1,147 Listeners

119 Listeners

194 Listeners

519 Listeners

68 Listeners

4 Listeners

375 Listeners

183 Listeners

187 Listeners

19 Listeners

6 Listeners